LEVOSULPIRIDE IN PREMATURE EJACULATION

Authors

  • Syed Javid Hussain
  • Atif Hameed
  • Hassan Shahzad Nazar
  • Ania Javid
  • Yousaf Shah
  • Waqas Hameed
  • Muhammad Shah Miran

Abstract

Background: Premature ejaculation is one of the most common sexual disorders. A large number oftreatment options have been used so far for the treatment of this dysfunction and still a large number ofexperts are doing research in this field. Here we have tried to research on the beneficial effects oflevosulpiride in the treatment of PE. Methods: Eighty-eight patients form different areas of Hazaradivision suffering from PE were chosen. Sixty-four patients were given levosulpiride and the remaining24 patients were given Placebo. Results: Out of 64 patients who have been given levosulpiride, 30patients showed very good improvement, 14 patients showed some improvement, 14 patients showedlittle and 06 patients showed no improvement. Conclusion: levosulpiride have very good beneficialeffects in the treatment of PE.Keywords: levosulpiride, premature ejaculation

References

Master VA, Johnson PJ. Ejaculatory physiology and dysfunction.

Urol. Clin. North Am. 2001;28(2):363–75.

Kinsey A, Pomeroy W, Martin C, & Gebhard P. Sexual

Behaviour in the Human Male, Philadelphia: Saunders (1953);

ISBN978-0253334114.

Ejaculation delay: what’s normal? Bandolier Books.

http://www.medicine.ox.ac.uk/bandolier/band137/b137-4.html.

Retrieved 2007-10-21.

Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer

DH, Boolell M. A multinational population survey of

intravaginal ejaculation latency time. J Sexual Med

:2(4):492–7.

Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH.

Proposal for a definition of lifelong premature ejaculation based

on epidemiological stopwatch data. J Sexual Med

;2(4):498–507.

Robert L. Marrone, Body of knowledge: an introduction to

body/mind psychology. Place of Publication: SUNY Press; 1990,

p. 104.

Böhlen D, Hugonnet CL, Mills RD, Weise ES, Schmid HP. Five

meters of H2O: the pressure at the urinary bladder neck during

human ejaculation. Prostate 2000 44(4):339–41.

Master VA, Johnson PJ. Ejaculatory physiology and dysfunction.

Urol Clin North Am 2001;28(2):363–75.

deGroat WC, Booth AM. Physiology of male sexual function.

Ann Intern Med 1980;92 (2 Pt 2): 329–31.

Truitt WA, Coolen LM (2002). Identification of a potential

ejaculation generator in the spinal cord. Science

;297(5586):1566–9.

Coolen LM, Olivier B, Peters HJ, Veening JG. Demonstration of

ejaculation-induced neural activity in the male rat brain using 5-

HT1A agonist 8-OH-DPAT. Physiol Behav 1997;62(4):881–91.

Premature Ejaculation. Premature Ejaculation and Male

Orgasmic Disorder. Armenian Medical Network 2006.

http://www.health.am/sex/premature-ejaculation/ Retrieved

-09-19.

Kendirci M, Salem E, Hellstrom WJ. Dapoxetine, a novel

selective serotonin transport inhibitor for the treatment of

premature ejaculation. Ther Clin Risk Manag 2007;3(2):277–89.

PPD Reports First Quarter 2009 Financial Results. Available at:

http://investor.ppdi.com/releasedetail.cfm?releaseid=492822

J Ayub Med Coll Abbottabad 2010;22(4)

http://www.ayubmed.edu.pk/JAMC/PAST/22-4/Javid.pdf

Janssen-Cilag EMEA announces receipt of first regulatory

approvals for Priligy for PE in Finland and Sweden, February 11,

Available from: http://www.tradingmarkets.com/.site/news/

Stock%20News/2170588/

Sidi AA, Cameron JS, Dykstra DD, Reinberg Y, Lange PH.

Vasoactive intracavernous pharmacotherapy for the treatment of

erectile impotence in men with spinal cord injury. J Urol

;138(3):539–42.

Downloads

Published

2010-12-01

Most read articles by the same author(s)